(Q30051055)

25 May 2017

1 reference

1 reference

A. Ougolkov

1

1 reference

25 May 2017

B. Zhang

2

1 reference

25 May 2017

K. Yamashita

3

1 reference

25 May 2017

V. Bilim

4

1 reference

25 May 2017

M. Mai

5

1 reference

25 May 2017

S. Y. Fuchs

6

1 reference

25 May 2017

T. Minamoto

7

1 reference

25 May 2017

language of work or name

English

0 references

publication date

3 August 2004

1 reference

Journal of the National Cancer Institute

25 May 2017

published in

1 reference

25 May 2017

volume

96

1 reference

25 May 2017

issue

15

1 reference

25 May 2017

page(s)

1161-1170

1 reference

The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis

25 May 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

Emerging concepts in colorectal neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

Blocking oncogenic Ras signaling for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

The oncogenic activation of beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

The Hedgehog and Wnt signalling pathways in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

Beta-catenin--a linchpin in colorectal carcinogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

Detection of oncogenes in the diagnosis of cancers with active oncogenic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

Tumor formation by genetic mutations in the components of the Wnt signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

beta-catenin is a target for the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

beta-Trcp couples beta-catenin phosphorylation-degradation and regulates Xenopus axis formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

The many faces of beta-TrCP E3 ubiquitin ligases: reflections in the magic mirror of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

Emi1 proteolysis: how SCF(beta-Trcp1) helps to activate the anaphase-promoting complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

Five human genes encoding F-box proteins: chromosome mapping and analysis in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

Induction of beta-transducin repeat-containing protein by JNK signaling and its role in the activation of NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

Inhibition of HOS expression and activities by Wnt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

Apoptosis in the pathogenesis and treatment of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

ATF4 degradation relies on a phosphorylation-dependent interaction with the SCF(betaTrCP) ubiquitin ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

Pseudosubstrate regulation of the SCF(beta-TrCP) ubiquitin ligase by hnRNP-U

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

NF-kappaB in cancer: from innocent bystander to major culprit

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

IkappaB kinase: beginning, not the end

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

Basic Medical Research Award. The ubiquitin system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

Ubiquitin-mediated proteolysis: biological regulation via destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

Ubiquitin-mediated degradation of cellular proteins in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

21 January 2018

MDM2: life without p53.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

p53-Mdm2--the affair that never ends

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

Strongly reduced expression of the cell cycle inhibitor p27 in endometrial neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

Inducible degradation of IkappaBalpha by the proteasome requires interaction with the F-box protein h-betaTrCP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

Impaired degradation of inhibitory subunit of NF-kappa B (I kappa B) and beta-catenin as a result of targeted disruption of the beta-TrCP1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

Inhibition of NF-kappa-B cellular function via specific targeting of the I-kappa-B-ubiquitin ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

NF-kappaB/rel/IkappaB: implications in gastrointestinal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

NF-kappaB at the crossroads of life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

Activators and target genes of Rel/NF-kappaB transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

Genetic evidence for the essential role of beta-transducin repeat-containing protein in the inducible processing of NF-kappa B2/p100

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

betaTrCP-mediated proteolysis of NF-kappaB1 p105 requires phosphorylation of p105 serines 927 and 932.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

Molecular genetic analysis of malignant melanomas for aberrations of the WNT signaling pathway genes CTNNB1, APC, ICAT and BTRC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

APC/CTNNB1 (?-catenin) pathway alterations in human prostate cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH219

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJH219

2 references

25 May 2017

Consolidated OpenCitations Corpus – April 2017

3380291

3380291

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference